Article
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.
British journal of cancer - 10 Dec 2013
Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, Mitry Emmanuel, Taieb J, Di Fiore F, Gornet J-M, Thirot-Bidault A, Sobhani I, Malka D, Lecomte T, Locher C, Bonnetain F, Laurent-Puig P
Abstract excerpt
BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare tumour with a poor prognosis. Molecular biology data on SBA carcinogenesis are lacking. METHODS: Expression of HER2, β-catenin, p53 and mismatch repair (MMR) protein was assessed by immunohistochemistry. KRAS, V600E BRAF mutations and microsatellite instability were investigated. RESULTS: We obtained samples from 63 SBA patients (tumour stages: I-II: 30%;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
